276 results on '"Dematteo R"'
Search Results
2. P2.12-02 Beware: Tyrosine Kinase Inhibitors for Lung Cancers that Inhibit MATE-1 can Lead to "False” Decreases in Renal Function
3. Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival
4. Survival after resection of perihilar cholangiocarcinoma—development and external validation of a prognostic nomogram
5. Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer
6. Long-term outcomes following microwave ablation for liver malignancies
7. Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases
8. Hepatic Arterial Nodal Metastases in Pancreatic Cancer: Is This the Node of Importance?
9. Malignant Progression in IPMN: A Cohort Analysis of Patients Initially Selected for Resection or Observation
10. Downstaging in Pancreatic Cancer: A Matched Analysis of Patients Resected Following Systemic Treatment of Initially Locally Unresectable Disease
11. 674P Response of thrombopoietin receptor agonists in MDM2 inhibitor induced thrombocytopenia
12. Rates and Patterns of Recurrence for Percutaneous Radiofrequency Ablation and Open Wedge Resection for Solitary Colorectal Liver Metastasis
13. The Role of Staging Laparoscopy in Hepatobiliary Malignancy: Prospective Analysis of 401 Cases
14. Staging laparoscopy for potentially resectable noncolorectal, nonneuroendocrine liver metastases
15. VASCULAR INFLOW CONTROL DURING HEPATIC LOBECTOMY: A COMPARISON OF INTRAHEPATIC PEDICLE LIGATION AND EXTRAHEPATIC LIGATION: PL23
16. HEPATIC ARTERIAL NODAL METASTASES IN PANCREATIC CANCER: IS THIS THE NODE OF IMPORTANCE?
17. Defining Postoperative Weight Change Following Pancreatectomy: Factors Associated With Distinct And Dynamic Weight Trajectories
18. Gallbladder Cancer (GBC): 10-Year Experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)
19. Liver resection after hepatic arterial infusion (HAI) plus systemic oxaliplatin (Oxal) combinations in pretreated patients with extensive unresectable colorectal liver metastases: 3542
20. Management of 155 patients with benign liver tumours
21. Lending a hand for laparoscopic distal pancreatectomy: The optimal approach?
22. Histopathological growth patterns and positive margins after resection of colorectal liver metastases
23. Preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma
24. Prediction of morbidity following cytoreductive surgery for metastatic gastrointestinal stromal tumour in patients on tyrosine kinase inhibitor therapy
25. Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram (vol 26, pg 1930, 2015)
26. Endoscopic versus percutaneous drainage of post-operative fluid collection following pancreatic resection
27. Proteomic evaluation of biliary exosomes implicates exportin7 in the pathogenesis of extrahepatic cholangiocarcinoma
28. Preoperative prediction of microvascular invasion in hepatocellular carcinoma using quantitative image analysis
29. Clinical utility of immunoglobulin-G4 in the diagnosis of autoimmune pancreatitis
30. Minimally invasive versus open segment 7 and 8 hepatic resection: a propensity score-matched comparison
31. Adjuvant hepatic arterial infusion chemotherapy is associated with superior survival after resection of colorectal liver metastases: A propensity score analysis of 2368 patients
32. Postoperative mortality after liver resection for perihilar cholangiocarcinoma: Importance of biliary drainage of the future liver remnant and development of a risk score
33. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO
34. Utility of image guidance in the localization of disappearing colorectal liver metastases
35. Patient Derived Cholangiocarcinoma Carcinoma Organoids Provide an Efficient Platform To Rapidly Assess Radiation and Chemotherapy Sensitivity
36. Long-term outcomes following microwave ablation for liver malignancies
37. CT and MRI of primary and metastatic fibrolamellar carcinoma: a case series of 37 patients
38. Malignant Progression in IPMN: A Cohort Analysis of Patients Initially Selected for Resection or Observation
39. Downstaging in Pancreatic Cancer: A Matched Analysis of Patients Resected Following Systemic Treatment of Initially Locally Unresectable Disease
40. Clinical/pathologic features and survival of patients with fibrolamellar-hepatocellular carcinoma (FLL-HCC): Data from the Fibrolamellar-Hepatocellular (FLL-HCC) Consortium.
41. Phase II single-arm, single-institution trial of neoadjuvant gemcitabine and oxaliplatin treatment (NT) in patients (pts) with resectable pancreas adenocarcinoma (PC).
42. Intraductal papillary neoplasm of the bile duct (IPNB): A biliary equivalent to IPMN of the pancreas?
43. A randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer.
44. Dynamic contrast enhanced MRI (DCE-MRI) to measure antiangiogenic therapy and predict treatment response in primary liver cancer (PLC).
45. Incidence and risk factors for biliary sclerosis following adjuvant hepatic arterial infusion with floxuridine after hepatectomy for metastatic colorectal cancer.
46. Gene expression profiles to predict outcome following liver resection in patients with metastasis of colorectal cancer.
47. Unexpected increased biliary toxicity when systemic bevacizumab is added to hepatic arterial infusion.
48. Use of T-cell proliferation to predict survival and recurrence in patients with resected colorectal liver metastases.
49. Adequate lymph node assessment for extrahepatic bile duct cancer: Do the data support the current AJCC recommendations?
50. Use of CXCR4 as a prognostic marker for disease-specific survival and pattern of recurrence following resection of hepatic colorectal metastases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.